Small Grants Program for Cancer Epidemiology R03 Federal Grant

Home

RESEARCH

ARTICLES

RESOURCES

Government Jobs
Grant Forums

FAST GRANT SEARCH

FEDERAL GRANTS NEWSLETTER

Small Grants Program for Cancer Epidemiology (R03)

The summary for the Small Grants Program for Cancer Epidemiology (R03) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

Federal Grant Title:	SMALL GRANTS PROGRAM FOR CANCER EPIDEMIOLOGY (R03)
Federal Agency Name:	National Institutes of Health
Program Name:	Cancer Construction
Grant Categories:	Education Health
CFDA Number:	93.392
Funding Opportunity Number:	PAR-08-237
Posted Date:	Oct 03, 2008
Creation Date:	Oct 03, 2008
Original Application Deadline:	Nov 19, 2011
Current Application Deadline:	Nov 19, 2011
Archive Date:	Dec 20, 2011
Total Program Funding:	Information not provided
Maximum Federal Grant Award:	Information not provided
Minimum Federal Grant Award:	Information not provided
Expected Number of Awards:	Information not provided
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
Grant Description: -Purpose. This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), encourages the submission of Small Research Grant (R03) applications for research on cancer etiology and epidemiology. The overarching goal of this FOA is to provide support for pilot projects, testing of new techniques, secondary analyses of existing data, development and validation of measurement methods, linkage of genetic polymorphisms with other variables related to cancer risk, and development of innovative projects for more comprehensive research in cancer etiology and epidemiology. -Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH Small Grant (R03) mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-08-237.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Epigenetic Approaches in Cancer Epidemiology (R01); • Innovative and Applied Emerging Technologies in Biospecimen Science (R33); • Innovative and Applied Emerging Technologies in Biospecimen Science (R21); • Innovative Technology Development for Cancer Research (R21); • Application and Use of Transformative Emerging Technologies in Cancer Research (R33); • Application and Use of Transformative Emerging Technologies in Cancer Research (R21)
More Grants from the National Institutes of Health: • Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...; • Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...; • Pediatric Critical Care and Trauma Scientist Development Program (K12); • Evidence-based Demonstration Projects in Immunization (Admin Supp); • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...